| Objective: | Global transitional registry of TAXUS® Express2™ Paclitaxel-Eluting Stent |
| Number of Patients: | 778 |
| Number of Sites: | 22 sites in 9 countries |
| Lesion Type: | de novo |
| Stent Platform: | TAXUS® Express2™ Paclitaxel-Eluting Stent |
| Release Kinetics: | Slow Release (SR) |
| Primary Endpoint: | 1-year site reported target lesion reinterventions |
| P.I. and Co-P.I.: | Alexandre Abizaid, MD |
| Status: | Enrollment Complete |
